Arrowhead Pharmaceuticals, Inc.

ARROWSTREET CAPITAL, LIMITED PARTNERSHIP ARWR

Report date

12/31/2025

Quarter

2025 Q4

Filed

2/13/2026

Shares

2,087,953

Value ($000)

138,619

Weight

0.1%

2019 Q4 - 2025 Q4 (4 filings)

Shares History

History scope: non-option holdings only (PUT/CALL rows excluded).

All 13F Holders	Filing date	Value ($000s)	% of Holdings	Shares	Reporting period
2025 Q4	2/13/2026	138,619	0.1%	2,087,953	12/31/2025
2025 Q3	11/13/2025	71,797	0.0%	2,081,689	9/30/2025
2025 Q2	8/13/2025	1,014	0.0%	64,200	6/30/2025
2019 Q4	2/13/2020	29,855	0.1%	470,679	12/31/2019